151 related articles for article (PubMed ID: 32129603)
21. Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats.
S S; S M; P S L S; S S; S B; V P
Int J Biol Macromol; 2017 Feb; 95():1190-1198. PubMed ID: 27825822
[TBL] [Abstract][Full Text] [Related]
22. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.
Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Tong Z; Kong X; Yao J
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):278-286. PubMed ID: 27770892
[TBL] [Abstract][Full Text] [Related]
23. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.
Haggag YA; Faheem AM; Tambuwala MM; Osman MA; El-Gizawy SA; O'Hagan B; Irwin N; McCarron PA
Pharm Dev Technol; 2018 Apr; 23(4):370-381. PubMed ID: 28285551
[TBL] [Abstract][Full Text] [Related]
24. A composite hydrogel system containing glucose-responsive nanocarriers for oral delivery of insulin.
Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Huang Q; Tong Z; Yao J; Kong X
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():37-45. PubMed ID: 27612686
[TBL] [Abstract][Full Text] [Related]
25. Methionine-Based pH and Oxidation Dual-Responsive Block Copolymer: Synthesis and Fabrication of Protein Nanogels.
Dong S; Jiang Y; Qin G; Liu L; Zhao H
Biomacromolecules; 2020 Oct; 21(10):4063-4075. PubMed ID: 32914964
[TBL] [Abstract][Full Text] [Related]
26. Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes.
Damgé C; Socha M; Ubrich N; Maincent P
J Pharm Sci; 2010 Feb; 99(2):879-89. PubMed ID: 19691099
[TBL] [Abstract][Full Text] [Related]
27. An Engineered Nanosugar Enables Rapid and Sustained Glucose-Responsive Insulin Delivery in Diabetic Mice.
Xu R; Bhangu SK; Sourris KC; Vanni D; Sani MA; Karas JA; Alt K; Niego B; Ale A; Besford QA; Dyett B; Patrick J; Carmichael I; Shaw JE; Caruso F; Cooper ME; Hagemeyer CE; Cavalieri F
Adv Mater; 2023 May; 35(21):e2210392. PubMed ID: 36908046
[TBL] [Abstract][Full Text] [Related]
28. Glucose- and temperature-sensitive nanoparticles for insulin delivery.
Wu JZ; Williams GR; Li HY; Wang D; Wu H; Li SD; Zhu LM
Int J Nanomedicine; 2017; 12():4037-4057. PubMed ID: 28603417
[TBL] [Abstract][Full Text] [Related]
29. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.
Yu J; Zhang Y; Ye Y; DiSanto R; Sun W; Ranson D; Ligler FS; Buse JB; Gu Z
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8260-5. PubMed ID: 26100900
[TBL] [Abstract][Full Text] [Related]
30. Microgel encapsulated nanoparticles for glucose-responsive insulin delivery.
Volpatti LR; Facklam AL; Cortinas AB; Lu YC; Matranga MA; MacIsaac C; Hill MC; Langer R; Anderson DG
Biomaterials; 2021 Jan; 267():120458. PubMed ID: 33197650
[TBL] [Abstract][Full Text] [Related]
31. An injectable particle-hydrogel hybrid system for glucose-regulatory insulin delivery.
Zhao F; Wu D; Yao D; Guo R; Wang W; Dong A; Kong D; Zhang J
Acta Biomater; 2017 Dec; 64():334-345. PubMed ID: 28974477
[TBL] [Abstract][Full Text] [Related]
32. Supersensitive Oxidation-Responsive Biodegradable PEG Hydrogels for Glucose-Triggered Insulin Delivery.
Zhang M; Song CC; Du FS; Li ZC
ACS Appl Mater Interfaces; 2017 Aug; 9(31):25905-25914. PubMed ID: 28714308
[TBL] [Abstract][Full Text] [Related]
33. pH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery.
Zhang C; Hong S; Liu MD; Yu WY; Zhang MK; Zhang L; Zeng X; Zhang XZ
J Control Release; 2020 Apr; 320():159-167. PubMed ID: 31978443
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.
Chuang EY; Lin KJ; Su FY; Mi FL; Maiti B; Chen CT; Wey SP; Yen TC; Juang JH; Sung HW
J Control Release; 2013 Dec; 172(2):513-22. PubMed ID: 23702234
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo testing of glucose-responsive insulin-delivery microdevices in diabetic rats.
Chu MK; Chen J; Gordijo CR; Chiang S; Ivovic A; Koulajian K; Giacca A; Wu XY; Sun Y
Lab Chip; 2012 Jul; 12(14):2533-9. PubMed ID: 22565220
[TBL] [Abstract][Full Text] [Related]
36. Phenylboronic acid-diol crosslinked 6-O-vinylazeloyl-d-galactose nanocarriers for insulin delivery.
Wu JZ; Bremner DH; Li HY; Niu SW; Li SD; Zhu LM
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():845-855. PubMed ID: 28482599
[TBL] [Abstract][Full Text] [Related]
37. Amphiphilic block versus random copolymer nanoparticles with reactive oxygen species responsiveness as berberine vehicles.
Guo H; Guo Q; Lan T; Luo Y; Pan X; Yao Y; Li Y; Feng Y; Liu Y; Tao L; Shen X
J Biomater Sci Polym Ed; 2021 Sep; 32(13):1657-1677. PubMed ID: 34024257
[TBL] [Abstract][Full Text] [Related]
38. Glucose and pH Dual-Responsive Polymersomes with Multilevel Self-Regulation of Blood Glucose for Insulin Delivery.
Zhou D; Li S; Fei Z; Zhou P; Zhao Y; Zhi L; Li C; Peng X; Liu X; Zhao C
Biomacromolecules; 2021 Sep; 22(9):3971-3979. PubMed ID: 34423981
[TBL] [Abstract][Full Text] [Related]
39. Glucose-Responsive Metal-Organic-Framework Nanoparticles Act as "Smart" Sense-and-Treat Carriers.
Chen WH; Luo GF; Vázquez-González M; Cazelles R; Sohn YS; Nechushtai R; Mandel Y; Willner I
ACS Nano; 2018 Aug; 12(8):7538-7545. PubMed ID: 29969227
[TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
Yang J; Sun H; Song C
Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
